Skip to main content
Article
Intraperitoneal Lymphokine-Activated Killer Cell/Interleukin-2 Therapy in Patients With Intra- abdominal Cancer: Immunologic Considerations
Journal of the National Cancer Institute (1989)
  • Walter J. Urba, National Institutes of Health
  • Jeffrey W. Clark, National Institutes of Health
  • Ronald G. Steis, National Institutes of Health
  • Michael A. Bookman, National Institutes of Health
  • John W. Smith, National Institutes of Health
  • Suzanne Beckner, National Institutes of Health
  • Annette E. Maluish, National Institutes of Health
  • Jeffrey L. Rossio, National Institutes of Health
  • Helen Rager, National Institutes of Health
  • John R. Ortaldo, National Institutes of Health
  • Dan L. Longo, National Institutes of Health
Publication Date
April 19, 1989
DOI
10.1093/jnci/81.8.602
Citation Information
Walter J. Urba, Jeffrey W. Clark, Ronald G. Steis, Michael A. Bookman, et al.. "Intraperitoneal Lymphokine-Activated Killer Cell/Interleukin-2 Therapy in Patients With Intra- abdominal Cancer: Immunologic Considerations" Journal of the National Cancer Institute Vol. 81 Iss. 8 (1989) p. 602 - 611
Available at: http://works.bepress.com/walter-urba/87/